Scarica l'app Stockscreener
1.66
0.00%
0.00
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CABA Giù?
Forum
Previsione
Precedente Chiudi:
$1.66
Aprire:
$1.66
Volume 24 ore:
675.81K
Relative Volume:
0.34
Capitalizzazione di mercato:
$84.23M
Reddito:
-
Utile/perdita netta:
$-67.68M
Rapporto P/E:
-1.00
EPS:
-1.66
Flusso di cassa netto:
$-54.24M
1 W Prestazione:
-0.60%
1M Prestazione:
-6.21%
6M Prestazione:
-33.60%
1 anno Prestazione:
-75.41%
Intervallo 1D:
$1.625
$1.71
Intervallo di 1 settimana:
$1.58
$1.73
Portata 52W:
$0.9857
$7.27
Cabaletta Bio Inc Stock (CABA) Company Profile
Nome
Cabaletta Bio Inc
Settore
Industria
Telefono
(267) 759-3100
Indirizzo
2929 ARCH STREET, PHILADELPHIA, PA
Confronta CABA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CABA
Cabaletta Bio Inc
|
1.66 | 149.31M | 0 | -67.68M | -54.24M | -1.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Cabaletta Bio Inc Stock (CABA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-20 | Downgrade | Evercore ISI | Outperform → In-line |
| 2024-12-19 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-10-10 | Iniziato | UBS | Buy |
| 2024-02-05 | Iniziato | Jefferies | Buy |
| 2023-11-29 | Iniziato | William Blair | Outperform |
| 2023-10-24 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-10-19 | Iniziato | Stifel | Buy |
| 2023-09-05 | Iniziato | Citigroup | Buy |
| 2023-07-18 | Iniziato | Guggenheim | Buy |
| 2023-01-27 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-08-30 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-08 | Iniziato | Wells Fargo | Overweight |
| 2021-10-19 | Ripresa | Morgan Stanley | Overweight |
| 2021-06-30 | Iniziato | Mizuho | Buy |
| 2021-01-08 | Iniziato | Chardan Capital Markets | Buy |
| 2020-10-13 | Iniziato | H.C. Wainwright | Buy |
| 2019-11-19 | Iniziato | Cowen | Outperform |
| 2019-11-19 | Iniziato | Evercore ISI | Outperform |
| 2019-11-19 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Cabaletta Bio Inc Borsa (CABA) Ultime notizie
How Resilient Is Occidental Petroleum Corporation Stock During Economic Downturns3x Return Stock Radar - Newser
What drives Cabaletta Bio Inc. stock priceRapid market gains - PrintWeekIndia
Why Cabaletta Bio Inc. stock is on top investor watchlistsSkyrocketing returns - jammulinksnews.com
What analysts say about Cabaletta Bio Inc. stockHigh-yield capital appreciation - Autocar Professional
Cabaletta Bio Inc. Stock Analysis and ForecastFree Stock Chart Pattern Guide - jammulinksnews.com
Why Cabaletta Bio Inc. stock attracts strong analyst attentionFree Best Performing Stock Alerts - Newser
Will Cabaletta Bio Inc. stock benefit from interest rate changesPredictable High Return Trades - Newser
Is Cabaletta Bio Inc. a good long term investmentPhenomenal wealth increase - Autocar Professional
Cabaletta Bio’s RESET-SLE Study: A Promising Step in Lupus Treatment - TipRanks
Cabaletta Bio’s RESET-MG Study: A Potential Game-Changer for Myasthenia Gravis Treatment - The Globe and Mail
What institutions are buying Cabaletta Bio Inc. stock nowFree Predictions - Newser
Cabaletta Bio’s RESET-Myositis Study: A Promising Step in Autoimmune Treatment - TipRanks
Cabaletta Bio’s RESET-MG Study: A Promising Step in Myasthenia Gravis Treatment - TipRanks
How Cabaletta Bio Inc. stock performs during market volatilityFree Wealth-Building Investment Strategies - beatles.ru
What makes Cabaletta Bio Inc. stock price move sharplyCapital Growth Picks - Newser
Cabaletta Bio’s RESET-Myositis Study: A Potential Game-Changer in Autoimmune Disease Treatment - TipRanks
Cabaletta Bio (NASDAQ:CABA) Stock Price Up 1.3%Here's What Happened - MarketBeat
Cabaletta Bio, Inc. (NASDAQ:CABA) Receives Average Recommendation of “Buy” from Analysts - Defense World
Cabaletta Bio, Inc. (NASDAQ:CABA) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Cabaletta Bio, Inc.(NasdaqGS: CABA) dropped from Russell 2000 Dynamic Index - MarketScreener
Cabaletta Bio, Inc.(NasdaqGS: CABA) dropped from Russell Microcap Growth Index - MarketScreener
Cabaletta Bio Inc Azioni (CABA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.97%
0.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):